The store will not work correctly when cookies are disabled.
3-ethoxycarbonyl-4-(4-methylphenyl)-4H-pyridine-1-carboxylic acid phenyl ester
ID: ALA229415
PubChem CID: 44424117
Max Phase: Preclinical
Molecular Formula: C22H21NO4
Molecular Weight: 363.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)C1=CN(C(=O)Oc2ccccc2)C=CC1c1ccc(C)cc1
Standard InChI: InChI=1S/C22H21NO4/c1-3-26-21(24)20-15-23(22(25)27-18-7-5-4-6-8-18)14-13-19(20)17-11-9-16(2)10-12-17/h4-15,19H,3H2,1-2H3
Standard InChI Key: JSLNJKCMEWUAAJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-2.2139 -5.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2151 -6.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5003 -7.0985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7838 -6.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7867 -5.8547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5021 -5.4455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5005 -7.9235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2180 -8.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2202 -9.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5076 -9.5738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7912 -9.1627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7874 -8.3351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5110 -10.3988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2271 -10.8084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7982 -10.8142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.9399 -10.3930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9320 -9.5684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6440 -9.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3611 -9.5628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3618 -10.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6492 -10.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0720 -7.9242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6416 -8.3383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0701 -7.0992 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5045 -4.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3570 -7.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0705 -8.3415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 13 1 0
1 2 2 0
13 14 1 0
7 3 1 0
13 15 2 0
7 8 1 0
14 16 1 0
3 4 2 0
16 17 2 0
17 18 1 0
4 5 1 0
18 19 2 0
2 3 1 0
19 20 1 0
5 6 2 0
20 21 2 0
21 16 1 0
7 12 1 0
12 22 1 0
8 9 2 0
22 23 1 0
9 10 1 0
22 24 2 0
10 11 1 0
6 25 1 0
11 12 2 0
23 26 1 0
6 1 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.41 | Molecular Weight (Monoisotopic): 363.1471 | AlogP: 4.55 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.84 | Molecular Species: ┄ | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.67 | CX LogD: 4.67 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.75 | Np Likeness Score: -0.20 |
References
1. Voigt B, Coburger C, Monár J, Hilgeroth A.. (2007) Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors., 15 (15): [PMID:17533131] [10.1016/j.bmc.2007.05.036] |